Cadrenal Therapeutics, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | +994.8% | +18.8% | -57.3% | |
| – | +1,067.2% | +19.1% | -57.3% | |
| – | +25,685.6% | +19.2% | -60.0% | |
| – | +25,685.6% | +19.2% | -60.0% | |
| – | – | +2.4% | -86.6% | |
| – | – | – | – | |
| – | -86.9% | +224.6% | -40.8% | |
| – | -38.0% | +224.6% | -40.8% | |
| – | -67.7% | – | – | |
| – | -58.7% | +798.0% | -56.7% | |
| – | – | – | – | |
| – | – | -3.3% | -63.2% | |
| – | – | – | – | |
| – | +11.9% | +40.5% | +63.5% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.